These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 21031002)
21. Overcoming the obstacles in the pharma/biotech industry: 2008 update. Graul AI; Revel L; Rosa E; Cruces E Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298 [TBL] [Abstract][Full Text] [Related]
22. Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study. Kesselheim AS; Wang B; Franklin JM; Darrow JJ BMJ; 2015 Sep; 351():h4633. PubMed ID: 26400751 [TBL] [Abstract][Full Text] [Related]
29. An overview of FDA-approved new molecular entities: 1827-2013. Kinch MS; Haynesworth A; Kinch SL; Hoyer D Drug Discov Today; 2014 Aug; 19(8):1033-9. PubMed ID: 24680947 [TBL] [Abstract][Full Text] [Related]
30. Could pharma open its drug freezers? Mullard A Nat Rev Drug Discov; 2011 Jun; 10(6):399-400. PubMed ID: 21629278 [No Abstract] [Full Text] [Related]
31. [Open innovation for Japanese pharmaceutical companies]. Hoshino T Nihon Yakurigaku Zasshi; 2013 Oct; 142(4):184-9. PubMed ID: 24107523 [No Abstract] [Full Text] [Related]
32. 2016 in review: FDA approvals of new molecular entities. Griesenauer RH; Kinch MS Drug Discov Today; 2017 Nov; 22(11):1593-1597. PubMed ID: 28687460 [TBL] [Abstract][Full Text] [Related]
33. The impact of external innovation on new drug approvals: A retrospective analysis. Liu X; Thomas CE; Felder CC Int J Pharm; 2019 May; 563():273-281. PubMed ID: 30664998 [TBL] [Abstract][Full Text] [Related]
34. Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009. Kaitin KI; DiMasi JA Clin Pharmacol Ther; 2011 Feb; 89(2):183-8. PubMed ID: 21191382 [TBL] [Abstract][Full Text] [Related]
36. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century. Kweder SL Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917 [No Abstract] [Full Text] [Related]
37. Recent trends in interorganizational deal networks in pharmaceutical and biotechnology industries. Yashiro K; Lim Y; Sengoku S; Kodama K Drug Discov Today; 2023 Mar; 28(3):103483. PubMed ID: 36584874 [TBL] [Abstract][Full Text] [Related]
38. Building a drug development database: challenges in reliable data availability. Audibert C; Romine M; Caze A; Daniel G; Leff J; McClellan M Drug Dev Ind Pharm; 2017 Jan; 43(1):74-78. PubMed ID: 27494335 [TBL] [Abstract][Full Text] [Related]